Saturday, February 16, 2019

AudioEye Delivers Next Generation Mobile Audio Website for Leading Cancer Journal

Onco'Zine - The International Cancer Network Launches Audio Internet™ Powered Website TUCSON, Ariz., May 16, 2013 /PRNewswire/ -- AudioEye®, Inc. (OTCBB: AEYE), the creators of the Audio Internet™, the patented audio browsing and automated publishing technology along with InPress Media Group, LLC, a specialized publishing and publication management company, announced that they have joined forces in offering AudioEye's Audio Internet...

High Unmet Need for Better-Tolerated Treatments Directed Toward Elderly Patients Drives Growth in Leukemia Market

Novel targeted therapies hold the most promise for improving outcomes for patients with acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML). This is the conclusion published in two reports by Decision Resources. Key Opinion Leaders (KOL) and medical experts interviewed for these reports are enthusiastic about the potential of blinatumomab (Amgen/MicroMet), a first-in-class bispecific T-cell engager.In phase II...

New Campaign Designed to Ensure that Young Girls are Protected Against Cervical Cancer

In the United Kingdom, almost 3,400 women are diagnosed with cervical cancer each year, representing nearly 2% of all women diagnosed with cancer. Cervical cancer is, however, the most common cancer in women under 35 years old.The major cause of the main types of cervical cancer - squamous cell cancer and adenocarcinoma - is HPV infection. While there...

TGen, Mayo Clinic and Scottsdale Healthcare Outline First Whole Genome Sequencing of Multiple Pancreatic Cancer Patients: Comparing Normal DNA with Mutations from Cancer Cells

Whole genome sequencing — spelling out all 3 billion letters in the human genome — “is an obvious and powerful method for advancing our understanding of pancreatic cancer,” according to a new study from TGen, Mayo Clinic and Scottsdale Healthcare published today.The Translational Genomics Research Institute/TGen demonstrated that the use of WGS “represents a compelling solution to obtaining detailed...

Bankruptcy and Cancer: Average Insolvency Rates Rise Fourfold Within Five Years of Diagnosis

An analysis linking federal bankruptcy court records to cancer registry data from nearly 232,000 adult cancer cases in western Washington during a 14-year period has found a hidden cost to survival: Insolvency rates increase along with the length of survival.“Patients diagnosed with cancer may face significant financial stress due to income loss and out-of-pocket costs associated with their treatment,”...

New Dutch Biotechnology Company Secures Funding to Develop Novel Oncology Therapeutics

Immunovo BV, a new biotechnology company developing a novel technology platform for the creation of a new generation of immunotherapeutics, has secured seed funding from Biox Biosciences BV and LUPUS Ventures BV. Immunovo combines the most desirable features of synthetic immunogen development with the recent insights into mechanisms driving tumor growth and metastasis, to create highly specific and powerful...

Dutch Diagnostic Company to Play Pivotal Role in ISPY-2 Trial for Breast Cancer

Netherlands genomics cancer diagnostics company, a world leader in molecular cancer diagnostics focused on the personalized medicine revolution striving to bring more effective, individualized treatments within reach of patients, will participate in the highly anticipated I-SPY 2 TRIAL for breast cancer, set to launch at the first of nearly twenty research sites.I-SPY 2 is an exciting and groundbreaking new...

New Discovery Health Channel Program Emphasizes Tailored, Individualized Treatment for Metastatic Breast Cancer

October (National Breast Cancer Awareness Month) is already weeks behind us but it remains imperative for both physicians and patients to keep up-to-date on the latest treatment developments for breast cancer, as well as all types of cancer.Metastatic breast cancer is breast cancer that has spread beyond the breast into places such as the bones, lungs, liver, or brain....

US-based TGen Drug Development and France’s Institut Paoli-Calmettes Create New Alliance Focuses on Cancer

TGen Drug Development (TD2), a Scottsdale subsidiary of the Phoenix-based the Translational Genomics Research Institute (TGen) providing innovative services for oncology-focused biopharmaceutical companies using and the Institut Paoli-Calmettes (IPC), a comprehensive cancer center in Marseille, France which is part of a network of 20 cancer treatment centers in France, have forged a strategic alliance that will enable both to...

GlaxoSmithKline and bioMerieux Sign Theranostics Agreement to Develop Predictive Test for Selecting Breast Cancer Treatment

France-based company bioMerieux, a world leader in the field of in vitro diagnostics for over 45 years and a provider of diagnostic solutions (reagents, instruments, software) designed to determine the source of disease and contamination to improve patient health and ensure consumer safety, has signed an agreement with GlaxoSmithKline (GSK) to develop a predictive test to help clinicians select...

right side

ads

Related articles